Spanish Biotech Database

INCHEON, South Korea, Sept. 21, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and AstraZeneca announced a long-term supply agreement, valued at approximately $330.8 million. Under this agreement, Samsung Biologics will provide large-scale commercial manufacturing for drug substance in its... Read more ››

By: PR Newswire Association LLC. - 22 Sep 2020

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 21 Sep 2020

Positive pivotal data for Libtayo® (cemiplimab) monotherapy in locally advanced basal cell carcinoma featured as a late-breaking presentation at ESMO

By: GlobenewsWire - 18 Sep 2020

Dr. Jean-Christophe Rufin appointed President of the Sanofi Espoir Corporate Foundation

By: GlobenewsWire - 18 Sep 2020

Setting new standards for speed and compatibility: Medit launches new T-Series scanner models

SEOUL, South Korea, Sept. 17, 2020 /PRNewswire/ -- Medit announces the launch of three new T-Series laboratory scanner models; T710, T510, and T310.

By: PR Newswire Association LLC. - 18 Sep 2020

ORYZON Presents Efficacy and Safety Results of its CLEPSIDRA Trial with Iadademstat in ED-SCLC Patients at ESMO-2020

By: GlobenewsWire - 17 Sep 2020

Related companies: Oryzon Genomics, S.A. | Oryzon Genomics

COVID-19: Menarini launches an antigen test that measures viral load

FLORENCE, Italy, Sept. 16, 2020 /PRNewswire/ -- Not just positive or negative, but also how much. The new test from A. Menarini Diagnostics to detect the presence of antigens can not only determine in just 12 minutes whether a patient is positive for COVID-19, but it also... Read more ››

By: PR Newswire Association LLC. - 16 Sep 2020

Gain Therapeutics Announces Research Collaboration with Sumitomo Dainippon Pharma Co., Ltd to Advance Gain’s Lysosomal Enzyme Allosteric Regulator Program

By: GlobenewsWire - 10 Sep 2020

Related companies: Gain Therapeutics, Barcelona | Gain Therapeutics SA

New England Journal of Medicine publishes positive final results from Phase 1/2a study of BIVV001 in people with severe hemophilia A

By: GlobenewsWire - 10 Sep 2020

« 1 2 3 4 5 6 7 8 »

Looking for companies outside of Spain?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

October 2020
- AusBiotech + Invest 2020
November 2020
- Precision in Clinical Trials Summit San Francisco
- Precision in Drug Discovery & Preclinical Summit

See Events »

Add an Event »

Latest company news

European Patent Office rules in favor of Sanofi and Regeneron concerning Praluent® (alirocumab)
29 Oct 2020 (GlobenewsWire)

Sanofi Q3 2020 business EPS(1) growth of 8.8% at CER
29 Oct 2020 (GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
29 Oct 2020 (GlobenewsWire)

News in the Life Sciences Industry

EMA accepts regulatory submission for avalglucosidase alfa, a potentially new standard of care enzyme replacement therapy for Pompe disease

Sanofi: Information concerning the total number of voting rights and shares - August 2020

Novo Nordisk A/S – Share repurchase programme

Sanofi completes Principia Biopharma Inc. acquisition

Availability of the Q3 2020 Memorandum for modelling purposes

World’s largest study of cardiovascular disease in type 2 diabetes shows need for improved knowledge and disease management

Allergy Therapeutics plc Preliminary Results for the year ended 30 June 2020

Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Principia Biopharma Inc.

Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply

Novo Nordisk A/S – Share repurchase programme

Positive pivotal data for Libtayo® (cemiplimab) monotherapy in locally advanced basal cell carcinoma featured as a late-breaking presentation at ESMO

Dr. Jean-Christophe Rufin appointed President of the Sanofi Espoir Corporate Foundation

Setting new standards for speed and compatibility: Medit launches new T-Series scanner models

ORYZON Presents Efficacy and Safety Results of its CLEPSIDRA Trial with Iadademstat in ED-SCLC Patients at ESMO-2020

COVID-19: Menarini launches an antigen test that measures viral load

Novo Nordisk A/S – Share repurchase programme

Sanofi : Information concerning the total number of voting rights and shares - July 2020

SK Biopharmaceuticals Initiates Clinical Development Program for Cenobamate in Asia

Gain Therapeutics Announces Research Collaboration with Sumitomo Dainippon Pharma Co., Ltd to Advance Gain’s Lysosomal Enzyme Allosteric Regulator Program

New England Journal of Medicine publishes positive final results from Phase 1/2a study of BIVV001 in people with severe hemophilia A

Looking for companies outside of Spain?

Partners

Upcoming Life Sciences Events

Latest company news